Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-20

Clinical Trial Update: Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating lipid biomarkers in men with dyslipidemia after simvastatin treatment, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2012-02-20